{
  "trial_id": "NCT00634517",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "TREATMENT REGIMENS",
      "label": "met",
      "evidence": "Albuterol-HFA (Treatment T) or Proventil-HFA (Treatment R)"
    },
    {
      "criterion": "CLINICAL VISITS",
      "label": "met",
      "evidence": "Three Clinical Visits with 14\u00b13 days intervals"
    },
    {
      "criterion": "METHODOLOGIES AND SPECIFIC MEASUREMENTS",
      "label": "met",
      "evidence": "Forced Expiratory Volume at 1st Second (FEV1) and Spirometry"
    }
  ],
  "exclusion": [
    {
      "criterion": "Any current or past significant medical conditions that, according to the investigator, might affect pharmacodynamic response to the study drugs",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Concurrent clinically significant cardiovascular, hematological, renal, neurological, hepatic, and endocrine disorders, or psychiatric diseases",
      "label": "unknown",
      "evidence": ""
    }
  ],
  "notes": "Patient has a history of asthma for 3 years, but is currently using inhaled corticosteroid (ICS) and fluticasone 500 mcg/salmeterol 50 mcg. He does not have any other significant medical conditions that might affect pharmacodynamic response to the study drugs.",
  "_meta": {
    "topic_id": "23",
    "trial_id": "NCT00634517",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}